Royal Bank of Canada lifted its target price for Aurinia Pharmaceuticals Inc. on October 9, 2026.
1 report, 1 independent
Updated Fri 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada lifted its target price for Aurinia Pharmaceuticals Inc. on October 9, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Royal Bank of Canada
financial institution in Canada
- Royal Bank of Canada lifted its position in the Dimensional U.S. Small Cap ETF, while several other firms increased their holdings on October 13, 2026.
- Financial institutions made various moves on June 18, 2026, including TD Cowen lowering its price objective, Citigroup raising its target, and Royal Bank of Canada increasing its target price. Separately, Man Group reduced its stock holdings.
Related events
- Royal Bank of Canada raised its target price for DCH.
- Royal Bank of Canada, Bank of America, and Morgan Stanley raised price targets for argenex.
- Royal Bank of Canada raised its target price for Freeport-McMoRan on October 1, 2026.
- Royal Bank of Canada, Morgan Stanley, and Jefferies Financial Group issued rating and price target updates for DPC Holdings Ltd.
- Royal Bank of Canada and Morgan Stanley updated their price targets for Broadridge Financial Solutions.